Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2023 Filed Jan 7, 2023 02:30 UTC |
Vitt DanielDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 300,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001193805-23-000020 · e618182_4-vitt.xml · derivative · entry 1 Vitt Daniel · CIK 0001773673 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2033-01-01 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 21:06 UTC |
Neermann JoergDirector
|
PurchaseCommon Stock | 47,000 | $1.26 | $59,032.00 |
DisclosureSEC source: 0001193805-22-001729 · e618126_4-jorg.xml · nonDerivative · entry 2 Neermann Joerg · CIK 0001773900 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.22 to $1.28 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought by him at each separate price on December 14, 2022. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:06 UTC |
Neermann JoergDirector
|
PurchaseCommon Stock | 35,000 | $1.25 | $43,610.00 |
DisclosureSEC source: 0001193805-22-001729 · e618126_4-jorg.xml · nonDerivative · entry 1 Neermann Joerg · CIK 0001773900 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.23 to $1.28 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought by him at each separate price on December 13, 2022. Read SEC document |
| November 23, 2022 Filed Nov 25, 2022 21:05 UTC |
Neermann JoergDirector
|
PurchaseCommon Stock | 18,000 | $1.39 | $25,020.00 |
DisclosureSEC source: 0001193805-22-001609 · e618059_4-jorg.xml · nonDerivative · entry 1 Neermann Joerg · CIK 0001773900 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 15:13 UTC |
Vitt DanielDirector · President and CEO
|
PurchaseCommon Stock | 8,000 | $1.35 | $10,799.20 |
DisclosureSEC source: 0001193805-22-001602 · e618054_4-vitt.xml · nonDerivative · entry 1 Vitt Daniel · CIK 0001773673 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 376,877 F1 · ownership.nature: 14,000 shares are owned directly by the Reporting Person and 362,877 shares are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 22:48 UTC |
Whaley GlennChief Financial Officer
|
PurchaseCommon Stock | 5,000 | $1.50 | $7,475.00 |
DisclosureSEC source: 0001193805-22-001497 · e618003_4-whaley.xml · nonDerivative · entry 1 Whaley Glenn · CIK 0001724623 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,510 F1 · balance_after: Includes a purchase of 2,568 shares on 11/30/21 and 2,942 shares on 5/31/22 under the IMUX employee stock purchase plan. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 16:07 UTC |
Toernsen Monika MariaDirector
|
GrantStock Option · Derivative | 30,000 | $0.00 Strike: $4.30 | $0.00 |
DisclosureSEC source: 0001193805-22-001090 · e621829_4-toernsen.xml · derivative · entry 1 Toernsen Monika Maria · CIK 0001873385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-07-08 F1 · derivative.exercise_date: 10,000 of the options vest in monthly increments over a period of one year from the grant date, and 20,000 of the options vest in monthly increments over a period of three years from the grant date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:35 UTC |
Muehler AndreasChief Medical Officer
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001193805-22-000973 · e621760_4-muehler.xml · derivative · entry 1 Muehler Andreas · CIK 0001850468 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. Read SEC document |
| June 15, 2022 Filed Jun 18, 2022 01:35 UTC |
Nash DuaneDirector · Executive Chairman
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001193805-22-000974 · e621761_4-duane.xml · derivative · entry 1 Nash Duane · CIK 0001591098 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. Read SEC document |
| June 15, 2022 Filed Jun 18, 2022 01:34 UTC |
PHILLIPS BARCLAY ADirector
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001193805-22-000972 · e621759_4-phillips.xml · derivative · entry 1 PHILLIPS BARCLAY A · CIK 0001265801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 15, 2022 Filed Jun 18, 2022 01:33 UTC |
Ossipow VincentDirector
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001193805-22-000971 · e621758_4-ossipow.xml · derivative · entry 1 Ossipow Vincent · CIK 0001773679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 15, 2022 Filed Jun 18, 2022 01:33 UTC |
Neermann JoergDirector
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001193805-22-000970 · e621757_4-jorg.xml · derivative · entry 1 Neermann Joerg · CIK 0001773900 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 15, 2022 Filed Jun 18, 2022 01:32 UTC |
Whaley GlennChief Financial Officer
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001193805-22-000969 · e621756_4-whaley.xml · derivative · entry 1 Whaley Glenn · CIK 0001724623 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. Read SEC document |
| June 15, 2022 Filed Jun 18, 2022 01:32 UTC |
Vitt DanielDirector · President and CEO
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001193805-22-000968 · e621755_4-vitt.xml · derivative · entry 1 Vitt Daniel · CIK 0001773673 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. Read SEC document |
| June 15, 2022 Filed Jun 18, 2022 01:31 UTC |
HOWSON TAMAR DDirector
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001193805-22-000967 · e621754_4-howson.xml · derivative · entry 1 HOWSON TAMAR D · CIK 0001202286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 15, 2022 Filed Jun 18, 2022 01:30 UTC |
van den Bossche JanDirector
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001193805-22-000966 · e621753_4-vdb.xml · derivative · entry 1 van den Bossche Jan · CIK 0001774052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 12:31 UTC |
Vitt DanielDirector · President and CEO
|
PurchaseCommon Stock | 5,000 | $3.10 | $15,499.50 |
DisclosureSEC source: 0001193805-22-000919 · e621729_4-vitt.xml · nonDerivative · entry 1 Vitt Daniel · CIK 0001773673 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 368,877 F1 · ownership.nature: 6,000 shares are owned directly by the Reporting Person and 362,877 shares are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 12:31 UTC |
Whaley GlennChief Financial Officer
|
PurchaseCommon Stock | 3,500 | $3.05 | $10,657.50 |
DisclosureSEC source: 0001193805-22-000918 · e621728_4-whaley.xml · nonDerivative · entry 1 Whaley Glenn · CIK 0001724623 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,568 Read SEC document |
| May 12, 2022 Filed May 13, 2022 12:31 UTC |
Whaley GlennChief Financial Officer
|
PurchaseCommon Stock | 3,000 | $5.08 | $15,240.00 |
DisclosureSEC source: 0001193805-22-000788 · e621653_4-whaley.xml · nonDerivative · entry 1 Whaley Glenn · CIK 0001724623 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,068 Read SEC document |
| May 12, 2022 Filed May 13, 2022 12:31 UTC |
Nash DuaneDirector · Executive Chairman
|
GiftCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-22-000787 · e621652_4-duane.xml · nonDerivative · entry 2 Nash Duane · CIK 0001591098 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,032 F2 · shares: Represents a gift of 6,000 shares. Read SEC document |
| May 12, 2022 Filed May 13, 2022 12:31 UTC |
Nash DuaneDirector · Executive Chairman
|
PurchaseCommon Stock | 10,000 | $5.03 | $50,300.00 |
DisclosureSEC source: 0001193805-22-000787 · e621652_4-duane.xml · nonDerivative · entry 1 Nash Duane · CIK 0001591098 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,032 F1 · shares: Represents a purchase of 10,000 shares. Read SEC document |
| May 12, 2022 Filed May 16, 2022 08:30 UTC |
Muehler AndreasChief Medical Officer
|
PurchaseCommon Stock | 3,500 | $5.10 | $17,850.00 |
DisclosureSEC source: 0001193805-22-000800 · e621657_4-muehler.xml · nonDerivative · entry 1 Muehler Andreas · CIK 0001850468 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,986 F1 · balance_after: Consists of 13,506 shares of common stock held directly by the Reporting Person and 284,480 shares of common stock held indirectly by Xanomed GmbH, an entity controlled by the Reporting Person. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 22:02 UTC |
Nash DuaneDirector · Executive Chairman
|
GrantStock Option · Derivative | 75,000 | $0.00 Strike: $10.88 | $0.00 |
DisclosureSEC source: 0001193805-22-000473 · e621442_4-duane.xml · derivative · entry 1 Nash Duane · CIK 0001591098 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-03-10 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 22:01 UTC |
Whaley GlennPAO and PFO
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $10.88 | $0.00 |
DisclosureSEC source: 0001193805-22-000472 · e621441_4-whaley.xml · derivative · entry 1 Whaley Glenn · CIK 0001724623 · PAO and PFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-03-10 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 16:02 UTC |
Muehler AndreasChief Medical Officer
|
GrantStock Option · Derivative | 100,000 | $0.00 Strike: $10.73 | $0.00 |
DisclosureSEC source: 0001193805-22-000017 · e621196_4-muehler.xml · derivative · entry 1 Muehler Andreas · CIK 0001850468 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-01-03 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 21:02 UTC |
Vitt DanielDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 215,000 | $0.00 Strike: $10.73 | $0.00 |
DisclosureSEC source: 0001193805-22-000018 · e621197_4-vitt.xml · derivative · entry 1 Vitt Daniel · CIK 0001773673 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Stock · 215,000 shares Expires 2032-01-03 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 21:01 UTC |
Whaley GlennPFO and PAO
|
GrantStock Option · Derivative | 70,000 | $0.00 Strike: $10.73 | $0.00 |
DisclosureSEC source: 0001193805-22-000016 · e621195_4-whaley.xml · derivative · entry 1 Whaley Glenn · CIK 0001724623 · PFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2032-01-03 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. Read SEC document |
| November 08, 2021 Filed Jan 3, 2022 13:00 UTC |
Nash DuaneDirector · Executive Chairman
|
GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-22-000002 · e621189_5-duane.xml · nonDerivative · entry 1 Nash Duane · CIK 0001591098 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,032 F1 · kind: Represents a gift of stock. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 13:05 UTC |
Whaley GlennPFO and PAO
|
PurchaseCommon Stock | 1,500 | $9.85 | $14,775.00 |
DisclosureSEC source: 0001193805-21-001163 · e620867_4-whaley.xml · nonDerivative · entry 1 Whaley Glenn · CIK 0001724623 · PFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 F1 · price: Reflects the weighted average price of 1,500 shares of common stock of Immunic, Inc. purchased by the Reporting Person in multiple transactions on August 10, 2021 at prices ranging from $9.65 to $9.95 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 13:04 UTC |
Vitt DanielDirector · President and CEO
|
PurchaseCommon Stock | 1,000 | $9.60 | $9,600.00 |
DisclosureSEC source: 0001193805-21-001161 · e620866_4-vitt.xml · nonDerivative · entry 1 Vitt Daniel · CIK 0001773673 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 363,877 F1 · ownership.nature: 1,000 shares are owned directly by the Reporting Person and 362,877 shares are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 13:02 UTC |
Nash DuaneDirector · Executive Chairman
|
PurchaseCommon Stock | 1,000 | $9.80 | $9,800.00 |
DisclosureSEC source: 0001193805-21-001159 · e620865_4-duane.xml · nonDerivative · entry 1 Nash Duane · CIK 0001591098 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,032 Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 23:13 UTC |
Nash DuaneDirector · Executive Chairman
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $14.77 | $0.00 |
DisclosureSEC source: 0001193805-21-000874 · e620712_4-duane.xml · derivative · entry 1 Nash Duane · CIK 0001591098 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-10 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:02 UTC |
Ossipow VincentDirector
|
GrantStock Option · Derivative | 25,000 | $0.00 Strike: $14.77 | $0.00 |
DisclosureSEC source: 0001193805-21-000868 · e620713_4-ossipow.xml · derivative · entry 1 Ossipow Vincent · CIK 0001773679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-06-10 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:02 UTC |
HOWSON TAMAR DDirector
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $14.77 | $0.00 |
DisclosureSEC source: 0001193805-21-000867 · e620711_4-howson.xml · derivative · entry 1 HOWSON TAMAR D · CIK 0001202286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-10 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:01 UTC |
Neermann JoergDirector
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $14.77 | $0.00 |
DisclosureSEC source: 0001193805-21-000865 · e620709_4-jorg.xml · derivative · entry 1 Neermann Joerg · CIK 0001773900 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-10 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:01 UTC |
PHILLIPS BARCLAY ADirector
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $14.77 | $0.00 |
DisclosureSEC source: 0001193805-21-000866 · e620710_4-phillips.xml · derivative · entry 1 PHILLIPS BARCLAY A · CIK 0001265801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-10 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:01 UTC |
van den Bossche JanDirector
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $14.77 | $0.00 |
DisclosureSEC source: 0001193805-21-000864 · e620708_4-vdb.xml · derivative · entry 1 van den Bossche Jan · CIK 0001774052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-10 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| May 12, 2021 Filed May 12, 2021 20:31 UTC |
Nash DuaneDirector · Executive Chairman
|
PurchaseCommon Stock | 4,000 | $12.75 | $51,000.00 |
DisclosureSEC source: 0001193805-21-000654 · e620591_4-duane.xml · nonDerivative · entry 1 Nash Duane · CIK 0001591098 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,032 Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 20:30 UTC |
Nash DuaneDirector · Executive Chairman
|
GrantStock Option · Derivative | 90,000 | $0.00 Strike: $15.44 | $0.00 |
DisclosureSEC source: 0001193805-21-000512 · e620490_4-duane.xml · derivative · entry 1 Nash Duane · CIK 0001591098 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2031-04-15 F1 · derivative.exercise_date: The shares underlying the option vest in twelve monthly installments beginning on May 15, 2021. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:31 UTC |
Whaley GlennPFO and PAO
|
PurchaseCommon Stock | 1,000 | $16.48 | $16,480.00 |
DisclosureSEC source: 0001193805-21-000324 · e620352_4-whaley.xml · nonDerivative · entry 1 Whaley Glenn · CIK 0001724623 · PFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| March 02, 2021 Filed Mar 15, 2021 17:05 UTC |
Muehler AndreasChief Medical Officer
|
PurchaseCommon Stock | 10,006 | $15.54 | $155,493.24 |
DisclosureSEC source: 0001193805-21-000368 · e620386_4-muehler.xml · nonDerivative · entry 1 Muehler Andreas · CIK 0001850468 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,486 F1 · price: Reflects the weighted average price of 10,006 shares of common stock of Immunic, Inc. purchased by the Reporting Person in multiple transactions on March 2, 2021 with sale prices ranging from $14.44 to $15.72 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. F2 · balance_after: Consists of 10,006 shares of common stock held directly by the Reporting Person, and 284,480 shares of common stock held indirectly by Xanomed GmbH, an entity controlled by the Reporting Person. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:31 UTC |
Whaley GlennPFO and PAO
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $15.72 | $0.00 |
DisclosureSEC source: 0001193805-21-000309 · e620344_4-whaley.xml · derivative · entry 1 Whaley Glenn · CIK 0001724623 · PFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-03-01 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:31 UTC |
Groeppel ManfredChief Operating Officer
|
GrantStock Option · Derivative | 45,000 | $0.00 Strike: $15.72 | $0.00 |
DisclosureSEC source: 0001193805-21-000308 · e620343_4-groppel.xml · derivative · entry 1 Groeppel Manfred · CIK 0001773674 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2031-03-01 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:31 UTC |
Vitt DanielDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 115,000 | $0.00 Strike: $15.72 | $0.00 |
DisclosureSEC source: 0001193805-21-000307 · e620342_4-vitt.xml · derivative · entry 1 Vitt Daniel · CIK 0001773673 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2031-03-01 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. Read SEC document |
| October 22, 2020 Filed Oct 22, 2020 23:40 UTC |
Nash DuaneDirector · Executive Chairman
|
GrantStock Option · Derivative | 120,000 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001193805-20-001306 · e620014_4-duane.xml · derivative · entry 1 Nash Duane · CIK 0001591098 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2030-10-22 F1 · derivative.exercise_date: The shares underlying the option vest in six monthly installments beginning on November 15, 2020. Read SEC document |
| August 10, 2020 Filed Aug 10, 2020 21:15 UTC |
Whaley GlennPFO and PAO
|
PurchaseCommon Stock | 1,000 | $18.96 | $18,960.00 |
DisclosureSEC source: 0001193805-20-000993 · e619850_4-whaley.xml · nonDerivative · entry 1 Whaley Glenn · CIK 0001724623 · PFO and PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 20:06 UTC |
Groeppel ManfredChief Operating Officer
|
SaleCommon Stock | 650 | $15.62 | $10,154.89 |
DisclosureSEC source: 0001193805-20-000880 · e619747_4-groppel.xml · nonDerivative · entry 2 Groeppel Manfred · CIK 0001773674 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 278,830 F1 · shares: These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Plan"). The Plan was adopted in connection with certain tax liabilities related to the issuance of shares in the April 2019 exchange transaction between the Issuer (then known as Vital Therapies, Inc.) and Immunic AG. F2 · ownership.nature: The Reporting Person is Director of Groeppel Investments UG (haftungsbeschrankt), which is the record holder of 278,830 shares of common stock of the Issuer, and exercises voting and dispositive power over such shares. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 20:05 UTC |
Vitt DanielDirector · Chief Executive Officer
|
SaleCommon Stock | 1,300 | $15.62 | $20,309.77 |
DisclosureSEC source: 0001193805-20-000879 · e619799_4-vitt.xml · nonDerivative · entry 2 Vitt Daniel · CIK 0001773673 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 362,877 F1 · shares: These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Plan"). The Plan was adopted in connection with certain tax liabilities related to the issuance of shares in the April 2019 exchange transaction between the Issuer (then known as Vital Therapies, Inc.) and Immunic AG. F2 · ownership.nature: The Reporting Person is Managing Director of Listrax UG (haftungsbeschrankt), which is the record holder of 362,877 shares of common stock of the Issuer, and exercises voting and dispositive power over such shares. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 20:06 UTC |
Groeppel ManfredChief Operating Officer
|
SaleCommon Stock | 5,000 | $14.44 | $72,200.50 |
DisclosureSEC source: 0001193805-20-000880 · e619747_4-groppel.xml · nonDerivative · entry 1 Groeppel Manfred · CIK 0001773674 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 279,480 F1 · shares: These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Plan"). The Plan was adopted in connection with certain tax liabilities related to the issuance of shares in the April 2019 exchange transaction between the Issuer (then known as Vital Therapies, Inc.) and Immunic AG. F2 · ownership.nature: The Reporting Person is Director of Groeppel Investments UG (haftungsbeschrankt), which is the record holder of 278,830 shares of common stock of the Issuer, and exercises voting and dispositive power over such shares. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 20:05 UTC |
Vitt DanielDirector · Chief Executive Officer
|
SaleCommon Stock | 5,000 | $14.44 | $72,200.50 |
DisclosureSEC source: 0001193805-20-000879 · e619799_4-vitt.xml · nonDerivative · entry 1 Vitt Daniel · CIK 0001773673 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 364,177 F1 · shares: These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Plan"). The Plan was adopted in connection with certain tax liabilities related to the issuance of shares in the April 2019 exchange transaction between the Issuer (then known as Vital Therapies, Inc.) and Immunic AG. F2 · ownership.nature: The Reporting Person is Managing Director of Listrax UG (haftungsbeschrankt), which is the record holder of 362,877 shares of common stock of the Issuer, and exercises voting and dispositive power over such shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.